Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Platinum-based two drug chemotherapy (cisplatin/carboplatin + vinorelbine or cisplatin/carboplatin + pemetrexed regimen)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-small Cell Lung Cancer Stage IIIA
1 trial -
Plozasiran
Arrowhead Pharmaceuticals Ireland Limited
Familial Chylomicronemia Syndrome
1 trial -
Plozasiran
Arrowhead Pharmaceuticals Ireland Limited
Familial Chylomicronemia
1 trial -
Plozasiran
Arrowhead Pharmaceuticals Ireland Limited
Severe Hypertriglyceridemia
1 trial -
Plozasiran Injection
Arrowhead Pharmaceuticals Ireland Limited
Severe Hypertriglyceridemia
2 trials -
Plozasiran Injection
Arrowhead Pharmaceuticals Ireland Limited
Hypertriglyceridemia
2 trials -
Plozasiran Injection Placebo, ARO-APOC3 PFS
Arrowhead Pharmaceuticals Ireland Limited
Severe hypertriglyceridemia (SHTG)
1 trial -
Plozasiran Injection Placebo, ARO-APOC3 PFS
Arrowhead Pharmaceuticals Ireland Limited
Severe hypertriglyceridemia (SHTG)
1 trial -
PolyCore
Lacuna Pharma Pty Ltd
Congestive Heart Failure
1 trial -
Polyamide HD membrane
Sionna Therapeutics
End-stage Kidney Disease
1 trial -
Ponesimod
Vanda Pharmaceuticals Netherlands B.V.
Moderate-to-severe Chronic Plaque Psoriasis
1 trial -
Pozelimab
Regeneron UK Limited
Paroxysmal Nocturnal Hemoglobinuria
4 trials -
Pozelimab + Cemdisiran
Regeneron UK Limited
Generalized Myasthenia Gravis
1 trial -
Pozelimab, Cemdisiran
Lacuna Pharma Pty Ltd
Paroxysmal nocturnal hemoglobinuria (PNH)
1 trial -
Pramipexol Extended Release
Boehringer Ingelheim
Early Parkinson Disease (Early PD)
1 trial -
Pravastatina Kern Pharma 40 mg comprimidos EFG, Placebo Pravastatina
The George Institute
intrauterine growth restriction, preeclampsia
1 trial -
Prednisolone
United Therapeutics Europe Ltd
Adrenal Insufficiency
1 trial -
Prednisolone 10mg Tablets, Avastin 25 mg/ml concentrate for solution for infusion., Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion
CERO THERAPEUTICS HOLDINGS, INC.
Brain metastases of cancer > brain radionecrosis
1 trial -
Pregabalin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Herpetic Neuralgia
1 trial -
Preoperative hepatic and regional arterial chemotherapy using oxaliplatin, MMC and FUDR
The First People's Hospital of Lianyungang
Colorectal Neoplasms
1 trial -
Priorix - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze|Masern-Mumps-Röteln-Lebendimpfstoff, Priorix - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze|Masern-Mumps-Röteln-Lebendimpfstoff, VARIVAX® Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension in einer Fertigspritze Varizellen-Lebendimpfstoff, Priorix - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze|Masern-Mumps-Röteln
GlaxoSmithKline
Varicella
1 trial -
Privigen 100 mg/ml solution for infusion, Gammanorm, 165 mg/ml, oplossing voor injectie, Octagam 10%, oplossing voor infusie, Nanogam 100 mg/ml oplossing voor infusie, Hizentra 200 mg/ml solution for subcutaneous injection, HyQvia 100 mg/ml solution for infusion for subcutaneous use, Cuvitru 200 mg/ml oplossing voor subcutane injectie, KIOVIG 100 mg/ml solution for infusion, CUTAQUIG 165 mg/mL, solution injectable, GAMMAGARD S/D 5,0 g, poeder en oplosmiddel voor oplossing voor infusie.
Disc Medicine
Primary antibody deficiency: - Unclassified antibody deficiency (unPAD) - IgA deficiency - Specific polysaccharide antibody deficiency (SPAD) - IgG subclass deficiency (IgSD) - Common variable immunodeficiency (CVID) - Agammaglobulinemia (X-linked or otherwise)
1 trial -
Progesterone
TherapeuticsMD
Secondary Amenorrhea
1 trial -
Progesterone
United Therapeutics Europe Ltd
Alcohol Dependence
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources